Key HighlightsCerenome (NASDAQ:CNSY), formerly Plus Therapeutics, was trading up 29.75% at USD 0.9997 on Friday, November 13, 2026, in market data, which implies a prior close near USD 0.77 (calculated); no company announcement explaining the move was found.The stock closed at USD 1.75 on …
The company describes itself as an accelerated compute platform for demanding AI workloads, built around large dedicated deployments. It sold its legacy Ekso Bionics business on September 30, 2026, which is why the quarter shows USD 16.1 million of discontinued operations. Revenue of USD …
Net income of USD 3.2 million included a USD 7.0 million decrease in the value of acquisition-related liabilities, which the company called non-recurring. Published coverage had expected a loss of USD 0.09 a share, so the comparison is not like for like. Removing it …
Revenue was about USD 27 million, adjusted EBITDA was a loss of about USD 10 million, andNet Incomewas USD 31.6 million against a net loss of USD 3.3 million a year earlier. The nine-month net loss was USD 350.2 million. After the report, published …
Coherent supplies lasers, optical components and transceivers for AI data centers and industrial uses.Capitalspending jumped to USD 776 million, and a published analysis said inventories rose about USD 760 million to USD 3.34 billion. Operating cash flow was negative USD 92.7 million. Cash and …
The company sells data protection, backup and cyber-resilience software. Market data shows fiscal second-quarterRevenueof USD 312.39 million, up 13.11% from a year earlier, but slightly below the USD 314.13 million of the prior quarter, a 0.6% sequential dip (calculated). Net income rose to USD …
The weak spot is the cost of capital. Net interest expense of USD 846 million in the quarter was about four times operating income of USD 207 million (calculated). Total debt was about USD 46.9 billion, and third-quarter financing included roughly USD 4.2 billion …
For the quarter ended July 31, 2026, revenue was USD 849.3 million, down 2.2%, with comparable restaurant sales down 2.1% and retail sales up 0.7%.GAAPNet Incomewas USD 12.2 million, or USD 0.54 a share. For the full year, adjusted EBITDA fell to USD 147.7 …
A published analysis said the largest part of Credo's recent decline followed the November 3 midterm elections, after which several winners campaigned on limits to data-center construction. On November 5, a published report said the S&P 500 fell 4.36% and AI and chip stocks …
Published coverage said Dell fell 8% on November 4 and a further 11% on November 5, 2026, with no company-specific news. It tied the moves to a wider technology selloff after the midterm elections. Reported factors included a newly elected Texas governor promising a …